Evidence map›Paper›PMID 40016317›Full record

Observational studyEuropean radiology2025

Preoperative breast MRI reduces reoperations for unilateral invasive lobular carcinoma: a patient-matched analysis from the MIPA study.

Andrea Cozzi, Giovanni Di Leo, Nehmat Houssami, Fiona J Gilbert, Thomas H Helbich, Marina Álvarez Benito, Corinne Balleyguier, Massimo Bazzocchi, Peter Bult, Massimo Calabrese and 35 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The Canadian Breast Cancer Symposium 2025: Meeting Report.Current oncology (Toronto, Ont.) · 2025
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors.

Andrea CozziUnit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Italy.
Giovanni Di LeoUnit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Italy.
Nehmat HoussamiThe Daffodil Centre, Faculty of Medicine and Health, The University of Sydney (Joint Venture with Cancer Council NSW), Sydney, Australia.
Fiona J GilbertDepartment of Radiology, School of Clinical Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
Thomas H HelbichDepartment of Biomedical Imaging and Image-guided Therapy, Division of General and Paediatric Radiology, Medical University of Vienna, Vienna, Austria.
Marina Álvarez BenitoDepartment of Radiology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Corinne BalleyguierDepartment of Radiology, Institut Gustave Roussy, Villejuif, France.
Massimo BazzocchiInstitute of Radiology, Department of Medicine, Ospedale Universitario S. Maria della Misericordia, Università degli Studi di Udine, Udine, Italy.
Peter BultDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Massimo CalabreseUnit of Oncological and Breast Radiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Julia Camps HerreroDepartment of Radiology, Hospital Universitario de La Ribera, Alzira, Spain.
Francesco CartiaUnit of Breast Imaging, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Enrico CassanoBreast Imaging Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Paola ClauserDepartment of Biomedical Imaging and Image-guided Therapy, Division of General and Paediatric Radiology, Medical University of Vienna, Vienna, Austria.
Marcos F de Lima DocemaDepartment of Radiology, Hospital Sírio Libanês, São Paulo, Brazil.
Catherine DeprettoUnit of Breast Imaging, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Valeria DominelliBreast Imaging Division, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Gábor ForraiDepartment of Radiology, MHEK Teaching Hospital, Semmelweis University, Budapest, Hungary.
Rossano GiromettiInstitute of Radiology, Department of Medicine, Ospedale Universitario S. Maria della Misericordia, Università degli Studi di Udine, Udine, Italy.
Steven E HarmsBreast Center of Northwest Arkansas, Fayetteville, AR, USA.
Sarah HilborneDepartment of Radiology, School of Clinical Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
Raffaele IenziDepartment of Radiology, Di.Bi.MED, Università degli Studi di Palermo, Policlinico Universitario Paolo Giaccone, Palermo, Italy.
Marc B I LobbesDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
Claudio LosioDepartment of Breast Radiology, IRCCS Ospedale San Raffaele, Milan, Italy.
Ritse M MannDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Stefania MontemezziDepartment of Radiology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Inge-Marie ObdeijnDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Umit Aksoy OzcanDepartment of Radiology, Acıbadem Atasehir Hospital, İstanbul, Turkey.
Federica PediconiDepartment of Radiological, Oncological and Pathological Sciences, Università degli Studi di Roma "La Sapienza", Rome, Italy.
Katja PinkerDepartment of Biomedical Imaging and Image-guided Therapy, Division of General and Paediatric Radiology, Medical University of Vienna, Vienna, Austria.
Heike PreibschDepartment of Diagnostic and Interventional Radiology, University Hospital of Tübingen, Tübingen, Germany.
José L Raya PovedanoDepartment of Radiology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Carolina Rossi SaccarelliDepartment of Radiology, Hospital Sírio Libanês, São Paulo, Brazil.
Daniela SacchettoKiwifarm S.r.l., La Morra, Italy.
Gianfranco P ScaperrottaUnit of Breast Imaging, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Margrethe SchloozDepartment of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Botond K SzabóDepartment of Radiology, Barking Havering and Redbridge University Hospitals NHS Trust, London, UK.
Donna B TaylorMedical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia.
Sıla Ö UlusDepartment of Radiology, Acıbadem Atasehir Hospital, İstanbul, Turkey.
Mireille Van GoethemGynecological Oncology Unit, Department of Obstetrics and Gynecology, Department of Radiology, Multidisciplinary Breast Clinic, Antwerp University Hospital, University of Antwerp, Antwerpen, Belgium.
Jeroen VeltmanMaatschap Radiologie Oost-Nederland, Oldenzaal, The Netherlands.
Stefanie WeigelClinic for Radiology and Reference Center for Mammography, University of Münster, Münster, Germany.
Evelyn WenkelDepartment of Radiology, University Hospital of Erlangen, Erlangen, Germany.
Chiara ZuianiInstitute of Radiology, Department of Medicine, Ospedale Universitario S. Maria della Misericordia, Università degli Studi di Udine, Udine, Italy.
Francesco SardanelliUnit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Italy. francesco.sardanelli@legatumori.mi.it.ORCID http://orcid.org/0000-0001-6545-9427

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the surgical impact of preoperative breast MRI in patients diagnosed with invasive lobular breast cancer (ILC) in a prospective observational study.

methodsThe prospective MIPA observational study database was queried for patients aged 18-80 with newly diagnosed unilateral ILC at needle biopsy referred for primary surgery. Patients who underwent preoperative MRI (MRI group) were matched (1:1) with those who did not (noMRI group) according to nine confounding covariates. Surgical outcomes were compared between the matched groups with nonparametric statistics after calculating odds ratios (ORs).

resultsA total of 547 women with unilateral needle biopsy-diagnosed ILC were identified (158 noMRI group, 389 MRI group). After patient matching, each group retained 103 patients, for a total of 206 matched patients. For the rate of women having a first-line mastectomy, there was no significant difference between the MRI group (21.4%, 22/103; p = 0.727; OR 1.20, 95% CI: 0.61-2.38) and the noMRI group (18.4%, 19/103). Conversely, the reoperation rate in the MRI group (1.9%, 2/103) was significantly lower (p = 0.007; OR of avoiding reoperation 7.29, 95% CI: 1.60-33.21) than in the noMRI group (12.6%, 13/103 patients). Overall mastectomy rates (first plus second-line) did not significantly differ between the MRI group (23.3%, 24/103; p = 0.867, OR 1.12, 95% CI: 0.58-2.16) and the noMRI group (21.4%, 22/103).

conclusionsWomen who had preoperative MRI after a needle biopsy diagnosis of ILC had a significant six-fold reduction in reoperations compared to those who did not have an MRI examination, with similar overall mastectomy rates. KEY POINTS: Question No randomized controlled trials investigating the impact of preoperative MRI on surgical outcomes (mastectomy rates and reoperation) of needle-biopsy-diagnosed ILC have been conducted. Findings In a patient-matched analysis of 103 vs 103 women, preoperative MRI led to a greater than six-fold reduction of reoperations, without significant differences in first-line and overall mastectomy rates. Clinical relevance In the absence of randomized controlled trials, patient matching can be applied to mitigate confounding factors that drive the referral to preoperative MRI, showing that preoperative MRI has beneficial effects on surgical outcomes in patients with needle biopsy-diagnosed unilateral ILC.

Indexed as

Breast NeoplasmsCarcinoma, LobularMagnetic Resonance ImagingPreoperative CareReoperationUnilateral Breast NeoplasmsAdolescentAdultAgedAged, 80 and overFemaleHumansMastectomyMiddle AgedNeoplasm InvasivenessProspective StudiesBreast neoplasmsCarcinoma (Lobular)Magnetic resonance imagingMastectomyReoperation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.